Published in JAMA on September 05, 2017
Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies | NCT01710215
Using Outreach to Improve Colorectal Cancer Screening. JAMA (2017) 0.75
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med (2014) 11.07
Shared decision making--pinnacle of patient-centered care. N Engl J Med (2012) 8.74
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med (2012) 7.18
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA (2016) 4.06
Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med (2012) 3.79
Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom (2008) 3.58
Shared decision making to improve care and reduce costs. N Engl J Med (2013) 3.48
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States? Gastroenterology (2004) 3.22
Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med (2013) 2.96
Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med (2014) 1.80
Quantification of harms in cancer screening trials: literature review. BMJ (2013) 1.77
Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol (2009) 1.46
Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst (2011) 1.33
The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev (2014) 1.30
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev (2016) 1.29
Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med (2010) 1.27
Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer (2011) 1.13
Participation, yield, and interval carcinomas in three rounds of biennial FIT-based colorectal cancer screening. Cancer Epidemiol (2015) 1.03
Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer (2015) 1.01
Adherence to repeat fecal occult blood testing in an urban community health center network. J Community Health (2013) 0.99
Use of colonoscopy for polyp surveillance in Medicare beneficiaries. Cancer (2013) 0.96
Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol (2010) 0.96
Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer (2013) 0.95
Harms of colonoscopy in a colorectal cancer screening programme with faecal occult blood test: a population-based cohort study. Dig Liver Dis (2013) 0.92
Clinical case management and navigation for colonoscopy screening in an academic medical center. Cancer (2013) 0.90
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer (2015) 0.90
Adherence to Competing Strategies for Colorectal Cancer Screening Over 3 Years. Am J Gastroenterol (2015) 0.89
Results of nurse navigator follow-up after positive colorectal cancer screening test: a randomized trial. J Am Board Fam Med (2014) 0.88
Endoscopic follow-up of positive fecal occult blood testing in the Ontario FOBT Project. Can J Gastroenterol (2007) 0.86
Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process. BMC Health Serv Res (2015) 0.84
Cancer Screening Test Use - United States, 2015. MMWR Morb Mortal Wkly Rep (2017) 0.80
How can we boost colorectal and hepatocellular cancer screening among underserved populations? Curr Gastroenterol Rep (2015) 0.79
Multilevel predictors of colorectal cancer testing modality among publicly and privately insured people turning 50. Prev Med Rep (2016) 0.77
Cost-effectiveness analysis of a colonoscopy screening navigator program designed for Hispanic men. J Cancer Educ (2015) 0.77
Predictors of guideline concordance for surveillance colonoscopy recommendations in patients at a safety-net health system. Cancer Causes Control (2015) 0.77
Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System. Am J Med (2016) 0.76
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system. Cancer (2015) 0.90
Mailed Outreach Program Increases Ultrasound Screening of Patients with Cirrhosis for Hepatocellular Carcinoma. Gastroenterology (2016) 0.76